Source: International Congress 2018 – Drug-resistant tuberculosis
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
S. Borisov (Moscow, Russian Federation), L. D’Ambrosio (Tradate, Italy), R. Centis (Tradate, Italy), K. Dheda (Cape Town, South Africa), J. Alffenaar (Groningen, Netherlands), R. Amale (Mumbai, India), E. Belilowski (Moscow, Russian Federation), J. Bruchfeld (Stockholm, Sweden), B. Canneto (Stockholm, Sweden), J. Denholm (Melbourne, Australia), R. Duarte (Porto, Portugal), A. Esmail (Cape Town, South Africa), A. Filippov (Moscow, Russian Federation), L. Davies Forsman (Stockholm, Sweden), M. Gaga (Athens, Greece), S. Ganatra (Mumbai, India), G. Igorevna (Arkhangelsk, Russian Federation), B. Lazaro Mastrapa (Upington, South Africa), V. Manfrin (Vicenza, Italy), S. Manga (Kiev, Ukraine), A. Maryandyshev (Arkhangelsk, Russian Federation), G. Massard (Strasbourg, France), P. GonzáLez Montaner (Buenos Aires, Argentina), J. Mullerpattan (Mumbai, India), D. Palmero (Buenos Aires, Argentina), A. Pontarelli (Sondalo, Italy), A. Papavasileiou (Athens, Greece), E. Pontali (Genova, Italy), R. Romero Leyet (Springbok, South Africa), A. Spanevello (Tradate, Italy), S. Tiberi (London, United Kingdom), A. Tramontana (Victoria, Australia), Z. Udwadia (Mumbai, India), P. Viggiani (Sondalo, Italy), D. Visca (Tradate, Italy), G. Sotgiu (Sassari, Italy), G. Migliori (Tradate, Italy). Outcomes of drug-resistant TB cases undergoing bedaquiline (BQ)-treatment and adjunctive surgery. 3672

Member's Comments

No comment yet.

Related content which might interest you: Treatment outcomes for XDR TB patients with surgery Source: Annual Congress 2007 - Multidrug-resistant tuberculosis and the emerging threat of extensively drug-resistant tuberculosis Year: 2007 Early outcomes in MDR-TB and XDR-TB patients treated with delamanid under compassionate use Source: Eur Respir J, 50 (1) 1700311; 10.1183/13993003.00311-2017 Year: 2017 Treatment results for MDR TB patients after surgery Source: Eur Respir J 2005; 26: Suppl. 49, 654s Year: 2005 Clinical efficacy of new anti-TB drug ²tubelon² during complex chemotherapy in patients with first-time diagnosed destuctive pulmonary TB Source: Eur Respir J 2006; 28: Suppl. 50, 8s Year: 2006 Long-term effectiveness of surgery treatment of TB patients Source: Virtual Congress 2020 – Tuberculosis and adverse events in different populations Year: 2020 Impact of XDR-TB on treatment outcome of MDR-TB patients with standardized regimens Source: Annual Congress 2008 - The challenge of multidrug-resistant tuberculosis Year: 2008 Outcomes of individualized treatment for MDR TB in Iran Source: Annual Congress 2007 - Medical and surgical treatment of susceptible and resistant tuberculosis Year: 2007 Experience of Bedaquiline use in treatment of XDR-TB patients Source: International Congress 2017 – TB: diagnosis, severity and practical management Year: 2017 Effectiveness and safety of six month chemotherapy course of XDR TB including bedaquiline and linezolid Source: International Congress 2016 – Rifampicin resistance, MDRTB, and new drug treatments Year: 2016 Effectiveness and safety of meropenem/clavulanate-containing regimens in the treatment of multidrug-resistant tuberculosis Source: International Congress 2016 – Rifampicin resistance, MDRTB, and new drug treatments Year: 2016 Efficacy of linezolide-free chemotherapy schemes in patients with highly drug-resistant tuberculosis Source: Virtual Congress 2021 – The ongoing threat of drug-resistant tuberculosis Year: 2021 Impact of pre-treatment duration by first line drugs on treatment outcomes of patients with MDR-TB Source: International Congress 2015 – TB treatment: new drugs and drug resistance Year: 2015 Prospects for early implementation of ambulatory treatment in XDR TB patients by optimizing the administration of linezolid at the intensive phase of chemotherapy Source: International Congress 2015 – TB treatment: new drugs and drug resistance Year: 2015 Final treatment outcomes of multidrug- and extensively drug-resistant tuberculosis patients in Latvia receiving delamanid-containing regimens Source: Eur Respir J, 50 (5) 1701105; 10.1183/13993003.01105-2017 Year: 2017 Efficacy of a standard chemotherapy regimen in the management of sputum-positive pulmonary TB relapses Source: Eur Respir J 2003; 22: Suppl. 45, 41s Year: 2003 Recurrence after successful treatment among patients with multidrug-resistant tuberculosis Source: Annual Congress 2011 - Risk factors and treatment outcomes in multidrug- and extensively drug-resistant tuberculosis Year: 2011 The incidence of multi drug resistant tuberculosis among patients receiving standardized treatment regimen for suspected MDR-TB Source: Annual Congress 2012 - MDR- and XDR-TB: clinical and public health experiences Year: 2012 Evaluation of failures treated with linezolid-containing regimen for extensively drug-resistant tuberculosis (XDR-TB) Source: International Congress 2015 – TB treatment: new drugs and drug resistance Year: 2015 Factors affecting the efficacy of treatment of MDR/XDR TB patients receiving bedaquiline Source: International Congress 2019 – Tuberculosis: a public health approach Year: 2019 Consecutive surgical treatment for bilateral fibro-cavernous pulmonary TB Source: International Congress 2015 – Case series and clinical conundrums in TB Year: 2015